| Literature DB >> 35120433 |
Genki Yoshimura1, Ryo Kamidani2, Tomotaka Miura1, Hideaki Oiwa1, Yosuke Mizuno1, Ryu Yasuda1, Yuichiro Kitagawa1, Tetsuya Fukuta1, Takahito Miyake1, Haruka Okamoto1, Norihide Kanda1, Tomoaki Doi1, Hideshi Okada1, Takahiro Yoshida1, Shozo Yoshida1, Shinji Ogura1.
Abstract
BACKGROUND: Leriche syndrome is caused by atherosclerosis and is often characterized by symptoms such as intermittent claudication and numbness and coldness of the lower limbs. Its exact prevalence and incidence are unknown because it is a rare disease. We report a case of Leriche syndrome diagnosed incidentally on trauma pan-scan computed tomography (CT). CASEEntities:
Keywords: Aortoiliac occlusive disease; Conservative treatment; Leriche syndrome; Trauma
Year: 2022 PMID: 35120433 PMCID: PMC8903668 DOI: 10.1186/s12245-022-00411-x
Source DB: PubMed Journal: Int J Emerg Med ISSN: 1865-1372
Laboratory findings on admission
| <Complete blood cell counts> | |
| White blood cells | 22,310 /μL |
| Red blood cells | 416 × 104 /μL |
| Hemoglobin | 12.5 g/dL |
| Platelet | 196 × 103 /μL |
| <Coagulation Status> | |
| Activated partial thromboplastin time | 26.2 s |
| Prothrombin time-international normalized ratio | 0.97 |
| Fibrinogen | 215 mg/dL |
| Fibrin degradation product | 104.6 μg/mL |
| D-dimer | 35.1 μg/mL |
| <Arterial Blood Gas> | |
| FiO2 | 1.0 |
| pH | 7.444 |
| PaCO2 | 30.9 mmHg |
| PaO2 | 154 mmHg |
| HCO3− | 20.8 mmol/L |
| Base Excess | −1.9 |
| Lactate | 36 mg/dL |
| <Biochemistry> | |
| Total protein | 5.7 g/dL |
| Albumin | 3.5 g/dL |
| Aspartate transaminase | 84 IU/L |
| Alanine transaminase | 64 IU/L |
| Lactate dehydrogenase | 341 IU/L |
| Alkaline phosphatase | 223 IU/L |
| Creatinine | 1.47 mg/dL |
| Blood urea nitrogen | 24.1 mg/dL |
| Total bilirubin | 0.4 mg/dL |
| Sodium | 138 mEq/L |
| Potassium | 4 mEq/L |
| Chloride | 106 mEq/L |
| C-reactive protein | 0.02 mg/dL |
| Blood sugar | 198 mg/dL |
| Hemoglobin A1c | 5.6% |
Fig. 1Coronal computed tomographic (CT) reconstructions in arterial phase images. A Complete occlusion just above the bifurcation of the abdominal aorta on 3D-CT image. In particular, the collateral blood pathway to the right external iliac artery can be seen. B Coronal contrast-enhanced CT images show disruption of blood flow due to bilateral thrombi at the aortic bifurcation and distal blood flow
Fig. 2Summary of the clinical course in the reported case. Change in creatine kinase (U/L) and myoglobin (ng/mL) per day after admission
Severity classification of acute lower limb arterial occlusive disease
| Class | Description/prognosis | Findings | Doppler signals | ||
|---|---|---|---|---|---|
| Sensory loss | Muscle weakness | Arterial | Venous | ||
| I:Viable | Not immediately threatened | None | None | Audible | Audible |
II:Threatened a:Marginal b:Immediate | Salvageable if promptly treated | Minimal (toes) or none | None | (Often) inaudible | Audible |
| Salvageable with immediate revascularization | More than toes, associated with rest pain | Mild, moderate | (Usually) inaudible | Audible | |
| III:Irreversible | Major tissue loss or permanent nerve damage inevitable | Profound, anesthetic | Profound, paralysis (rigor) | Inaudible | Inaudible |
Fig. 3Algorithm for the management of acute lower limb arterial occlusion. This algorithm was adapted from the TransAtlantic InterSociety Consensus for the management of peripheral arterial disease (TASC II) [8]